Skip to main content
. 2023 Apr 3;11:1147566. doi: 10.3389/fped.2023.1147566

Table 1.

Study participant characteristics.

Characteristica Number of individuals
Gender identity
Man 4
Non-binary 0
Woman 24
Race/ethnicity
Aboriginal/American Indian/Alaska Native 0
Asian 7
Asian-White 1
Black or African American 0
Hispanic, Latino, or Spanish origin 0
Middle Eastern or North African 2
Native Hawaiian or Other Pacific Islander 0
White 18
Primary practice setting and role
Midwifery
 Nurse Midwife 3
Neonatology
 Neonatologist 2
 Pharmacist 2
 Registered Nurse 1
Obstetrics
 Obstetrician 1
 Pharmacist 1
 Registered Nurse 1
Pediatrics
 Nurse Practitioner 1
 Pediatrician 3
 Pharmacist 1
 Teratogen/Lactation Information Specialistb 4
Adult Critical Care
 Pharmacist 1
Community Pharmacy
 Pharmacist 4
 Emergency Medicine
 Pharmacist 1
Family Medicine
 Physician 2
Experience providing or advising care for lactating breastfeeding
<1 year 0
1–3 years 2
4–6 years 2
>6 years 24
Frequency of patient or other healthcare provider inquiries on medication risk while breastfeeding
Daily 4
Weekly 10
Monthly 12
Less than Monthly 2
a

For demographics questions regarding identity, participants had the options of selecting “prefer not to disclose” and “prefer not to say”.

b

Participants’ primary role was defined as Teratogen/Lactation Information Specialist and their healthcare provider roles included Genetic Counsellors, Nurse Practitioners, and Registered Nurses.